Basimane Bisimwa P, Koyaweda G, Bihehe Masemo D, Ayagirwe R, Birindwa A, Bisimwa P
PLoS One. 2024; 19(7):e0292473.
PMID: 38959256
PMC: 11221749.
DOI: 10.1371/journal.pone.0292473.
Teame G, Gebreyesus A, Tsegay E, Gebretsadik M, Adane K
AIDS Res Ther. 2022; 19(1):57.
PMID: 36457041
PMC: 9714192.
DOI: 10.1186/s12981-022-00479-8.
Seyoum E, Demissie M, Worku A, Mulu A, Abdissa A, Berhane Y
PLoS One. 2022; 17(4):e0267230.
PMID: 35452472
PMC: 9032368.
DOI: 10.1371/journal.pone.0267230.
Mawouma A, Djoulatou A, Komnang E, Kimessoukie E
Pan Afr Med J. 2022; 41:61.
PMID: 35371374
PMC: 8933451.
DOI: 10.11604/pamj.2022.41.61.32627.
Shrestha L, Yadav G, Pradhan S, Sharma A, Pandit T, Chhetry R
PLoS One. 2022; 17(3):e0264791.
PMID: 35239716
PMC: 8893711.
DOI: 10.1371/journal.pone.0264791.
HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases.
Cheng Z, Lin P, Cheng N
Front Med (Lausanne). 2021; 8:713981.
PMID: 34676223
PMC: 8524435.
DOI: 10.3389/fmed.2021.713981.
Epidemiology and Challenges of HBV/HIV Co-Infection Amongst HIV-Infected Patients in Endemic Areas: Review.
Weldemhret L
HIV AIDS (Auckl). 2021; 13:485-490.
PMID: 33981165
PMC: 8107003.
DOI: 10.2147/HIV.S273649.
Perinatal transmission of hepatitis C virus: an update.
El-Shabrawi M, Kamal N, Mogahed E, Elhusseini M, Aljabri M
Arch Med Sci. 2020; 16(6):1360-1369.
PMID: 33224335
PMC: 7667440.
DOI: 10.5114/aoms.2019.83644.
The seropervelance of infectious hepatitis viruses (HBV, HCV and HEV) among blood donors and their correlation to risk factors in Qena governorate, Upper Egypt.
Ahmed A, Temerk H, Galal H, Bazeed S, Sultan S
Virusdisease. 2020; 31(3):292-298.
PMID: 32904769
PMC: 7459025.
DOI: 10.1007/s13337-020-00589-9.
Prevalence of Hepatitis B Surface Antigen and Antibodies to Hepatitis C in the General Population of Benue State, Central Nigeria.
Malu A, Achinge G, Utoo P, Kur J, Obekpa S
Am J Trop Med Hyg. 2020; 102(5):995-1000.
PMID: 32043452
PMC: 7204600.
DOI: 10.4269/ajtmh.19-0649.
Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana.
de Mendoza C, Bautista J, Perez-Benavente S, Kwawu R, Fobil J, Soriano V
Ther Adv Infect Dis. 2019; 6:2049936119851464.
PMID: 31205689
PMC: 6535694.
DOI: 10.1177/2049936119851464.
Seroprevalence of Hepatitis B Virus and Compliance to Standard Safety Precautions among Scavengers in Ilorin Metropolis, Kwara State, Nigeria.
Yusuf R, Sawyerr H, Adeolu A, Habeeb L, Abolayo T
J Health Pollut. 2018; 8(19):180914.
PMID: 30524873
PMC: 6257166.
DOI: 10.5696/2156-9614-8.19.180914.
Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon.
Ndjoyi-Mbiguino A, Kombe Kombe A, Bivigou-Mboumba B, Zoa-Assoumou S, Akombi F, Nzengui Nzengui F
PLoS One. 2018; 13(1):e0190529.
PMID: 29385148
PMC: 5791959.
DOI: 10.1371/journal.pone.0190529.
Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
Bivigou-Mboumba B, Amougou-Atsama M, Zoa-Assoumou S, Mboyis Kamdem H, Nzengui-Nzengui G, Ndojyi-Mbiguino A
PLoS One. 2018; 13(1):e0190592.
PMID: 29315352
PMC: 5760027.
DOI: 10.1371/journal.pone.0190592.
HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
Chambal L, Gudo E, Carimo A, Corte Real R, Mabunda N, Maueia C
PLoS One. 2017; 12(7):e0181836.
PMID: 28759595
PMC: 5536281.
DOI: 10.1371/journal.pone.0181836.
[Prevalence of hepatitis B surface antigen and its associated factors in Senegalese military personnel sent on mission to Darfur].
Diop M, Diouf A, Seck S, Lo G, Ka D, Massaly A
Pan Afr Med J. 2017; 26:154.
PMID: 28533877
PMC: 5429464.
DOI: 10.11604/pamj.2017.26.154.11594.
Hepatitis B virus and its sexually transmitted infection - an update.
Inoue T, Tanaka Y
Microb Cell. 2017; 3(9):420-437.
PMID: 28357379
PMC: 5354569.
DOI: 10.15698/mic2016.09.527.
Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey.
Olayinka A, Oyemakinde A, Balogun M, Ajudua A, Nguku P, Aderinola M
Am J Trop Med Hyg. 2016; 95(4):902-907.
PMID: 27527630
PMC: 5062798.
DOI: 10.4269/ajtmh.15-0874.
Cancer prevention in HIV-infected populations.
Goncalves P, Montezuma-Rusca J, Yarchoan R, Uldrick T
Semin Oncol. 2016; 43(1):173-188.
PMID: 26970136
PMC: 4789150.
DOI: 10.1053/j.seminoncol.2015.09.011.
Early-life exposures to infectious agents and later cancer development.
Vedham V, Verma M, Mahabir S
Cancer Med. 2015; 4(12):1908-22.
PMID: 26377256
PMC: 4940808.
DOI: 10.1002/cam4.538.